Inventor
David Knight
Inventor
Berwyn, PA, US
Overview
Patents· 92 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides30%
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
Y02ATechnologies for adaptation to climate change3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
A01KAnimal husbandry1%
C12NMicroorganisms or enzymes1%
C40BCombinatorial chemistry0%
PatentTitleYear
11,060,273Laminated bamboo platform and concrete composite slab system202110,901,008Energy harvest split core design elements for ease of installation, high performance, and long term reliability202110,519,231Method for treating lupus by administering an anti-IL-12 antibody201910,259,867Method for treating lupus by administering an anti-IL-12 antibody20199,862,766'Method of treating lupus by administering an anti-IL-12 antibody'20189,828,424Anti-TNF antibodies, compositions, methods and uses20179,676,848'Anti-IL-12 antibodies and compositions'20179,631,016'Pen-injector device containing anti-IL-6 antibodies'20179,605,067'Nucleic acids encoding anti-IL-12 antibody'20179,481,734'Immunoglobulin cleavage fragments and disease indicators and compositions for detecting and binding such'20169,428,579'Method of treating Crohn\'s disease by administering an anti-IL-12 antibody'20169,409,984'Method for treating psoriasis by administering an anti-IL-12 antibody'20169,340,613'Anti-IL-6 antibodies, compositions, methods and uses'20169,321,836'Anti-TNF antibodies, compositions, methods and uses'20169,062,305'Generation of human de novo pIX phage display libraries'20158,894,990'Method for treating psoriatic arthritis by administering an anti-IL-12 antibody'20148,703,141'Method for treating Crohn\'s disease by administering an anti-IL-12 antibody'20148,623,362'Anti-IL-6 antibodies'20148,603,778'Anti-TNF antibodies, compositions, methods and uses'20138,501,907'Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such'20138,329,170'Method for treating psoriasis by administering an anti-IL-12 antibody'20128,329,171'Method for treating psoriatic arthritis by administering an anti-IL-12 antibody'2012RE043672'Anti-IL-6 antibodies, compositions, methods and uses'20128,241,899'Anti-TNF antibodies, compositions, methods and uses'20128,226,611'Anti-IL-6 antibodies, compositions, methods and uses'20128,153,583'Toll like receptor 3 antagonists, methods and uses'20128,084,233'Nucleic acids encoding anti-IL-12 antibody'20118,080,247'Anti-IL-12 antibodies'20118,067,003'Methods of treating conditions using anti-IL-6 antibodies'20117,955,597'Anti-IL-6 antibodies, compositions, methods and uses'20117,887,807'Anti-IL-12 antibodies and compositions'20117,833,755'Anti-IL-6 antibody nucleic acid molecules and methods'20107,833,786'Anti-IL-6 antibodies, compositions, methods and uses'20107,820,169'Anti-TNF antibodies, compositions, methods and uses'20107,815,909'Anti-TNF antibodies, compositions, methods and uses'20107,744,885'Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereof'20107,718,176'Human EPO mimetic hinge core mimetibodies, compositions, methods and uses'20107,691,378'Anti-TNF antibodies, compositions, methods and uses'20107,612,182'Anti-IL-6 antibodies, compositions, methods and uses'20097,560,247'Nucleic acids encoding anti-IL-12 antibodies, and methods of production'20097,560,112'Anti-il-6 antibodies, compositions, methods and uses'20097,521,206'Anti-TNF antibodies, compositions, methods and uses'20097,425,330'Methods of inhibiting TNFα activity in the blood of a patient'20087,416,729'Methods of treating rheumatoid arthritis with anti-TNF antibodies'20087,404,955'Methods of inhibiting or neutralizing TNFα in patients with tissue injury'20087,393,662'Human EPO mimetic hinge core mimetibodies, compositions, methods and uses'20087,374,761'Recombinant A2-specific TNFα-specific antibodies'20087,335,358'Methods of treating psoriasis with anti-TNF antibodies'20087,291,721'Anti-IL-6 antibodies, compositions, methods and uses'20077,279,157'Method for treating psoriasis by administering an anti-il-12 antibody'20077,276,239'Recombinant A2-specific TNFα-specific antibodies'20077,252,823'Recombinant A2-specific TNFα-specific antibodies'20077,250,165'Anti-TNF antibodies, compositions, methods and uses'20077,241,733'Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses'20077,226,593'Methods of treating cachexia with chimeric anti-TNF antibodies'20077,227,003'Anti-TNF antibody fragments'20077,223,396'Methods of treatment of fistulas in Crohn\'s disease with anti-TNF antibodies'20077,214,376'Methods of inhibiting TNFα in patients with neoplastic disease'20077,204,985'Methods of treating disseminated intravascular coagulation by multiple administration of anti-TNF antibodies'20077,192,584'Methods of treating psoriasis with anti-TNF antibodies'20077,179,893'Recombinant anti-TNF-α antibodies'20077,179,466'Methods of treating rheumatoid arthritis by multiple administration of anti-TNF antibodies'20077,169,386'Methods of treating inflammation associated with viral infection with anti-TNF antibodies'20077,169,388'Methods of inhibiting TNFα in patients with cancer'20077,166,285'Anti-IL-12 antibodies and compositions'20077,166,284'Methods of treating joint inflammation with anti-TNF antibodies'20077,160,995'DNA encoding anti-TNF antibodies and peptides'20077,160,543'Methods of inhibiting TNF-α in patients with Crohn\'s disease'20077,160,542'Method of treating psoriasis using human anti-TNF antibodies and fragments'20077,138,118'Methods of treating rheumatoid arthritis with anti-TNF antibodies'20067,135,178'Methods of treating disseminated intravascular coagulation using anti-TNF antibodies'20067,135,179'Methods for treating sarcoidosis using anti-TNF antibodies and fragments thereof'20067,128,908'Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof'20067,128,907'Methods of treating crohn\'s disease with anti-TNF antibodies'20067,101,674'Anti-idiotypic anti-TNF antibodies and related immunoassay methods'20067,070,775'Recombinant A2-specific TNFα specific antibodies'20067,063,964'Nucleic acids encoding IL-12 antibody'20067,037,496'Chimeric immunoglobulin for CD4 receptors'20066,991,791'Anti-TNF antibodies and peptides of human tumor necrosis factor'20066,902,734'Anti-IL-12 antibodies and compositions thereof'20056,835,823'Anti-TNF antibodies and peptides of human tumor necrosis factor'20046,790,444'Anti-TNF antibodies and peptides of human necrosis factor'20046,652,863'Method of reducing the immunogenicity of compounds'20036,284,471'Anti-TNFa antibodies and assays employing anti-TNFa antibodies'20016,277,969'Anti-TNF antibodies and peptides of human tumor necrosis factor'20015,976,532'Method of antithrombotic therapy using anti-GPIIb/IIIa antibodies or fragments thereof, including c7E3'19995,919,452'Methods of treating TNF.alpha.-mediated disease using chimeric anti-TNF antibodies'19995,877,006'DNAs encoding chimeric immunoglobulin light or heavy chains and fragments thereof having variable regions derived from monoclonal antibody 7E3, and vectors and host cells comprising same'19995,770,198'Platelet-specific chimeric 7E3 immunoglobulin'19985,698,195'Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies'19975,656,272'Methods of treating TNF-.alpha.-mediated Crohn\'s disease using chimeric anti-TNF antibodies'19974,910,132'Virus-free in vitro assay for anti-HIV agents'1990Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1990–1999Based in Paoli, PA, US· patent location history
1997–2012Patents assigned to CENTOCOR INC (47)· patent assignee history
1997–2019Based in Berwyn, PA, US· patent location history
1999–2010Patents assigned to UNIV NEW YORK (21)· patent assignee history
2006–2017Patents assigned to KNIGHT DAVID M (13)· patent assignee history
2006–2017Patents assigned to GILES-KOMAR JILL (8)· patent assignee history
2011–2019Patents assigned to JANSSEN BIOTECH INC (24)· patent assignee history
2015Based in Radnor, PA, US· patent location history
2021Based in Bainbridge Island, WA, US· patent location history
2021Based in Mountain View, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CENTOCOR INC | 47 | 1997–2012 |
| JANSSEN BIOTECH INC | 24 | 2011–2019 |
| UNIV NEW YORK | 21 | 1999–2010 |
| KNIGHT DAVID Mself | 13 | 2006–2017 |
| GILES-KOMAR JILL | 8 | 2006–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Berwyn, Pennsylvania, US | 84 | 1997–2019 |
| Paoli, Pennsylvania, US | 4 | 1990–1999 |
| Bainbridge Island, Washington, US | 1 | 2021 |
| Mountain View, California, US | 1 | 2021 |
| Radnor, Pennsylvania, US | 1 | 2015 |